TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ENLIVEN THERAPEUTICS (ELVN) insider trades

ENLIVEN THERAPEUTICS (ELVN) insider trading activity (SEC Form 4). Over the trailing 90 days, ELVN insiders filed 0 purchases totalling $0 and 9 sales totalling $63.2M — net SELLING of $63.2M. Most recent filing: Aug 6, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
9
$63.2M
Net (90d)
-$63.2M
net selling
Most recent
Aug 6, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 6, 2026Derynck Mika KDirS SaleOE—$60.21$9.6Mfiling
Jul 21, 2026Hohl BenjaminCFOS SaleOE—$52.64$317Kfiling
Jul 21, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERS SaleOE—$52.67$263Kfiling
Jul 8, 2026Kunkel Lori AnneDirS Sale—$50.49$505Kfiling
Jun 24, 2026Orbimed Advisors LLC10%S Sale—$45.36$39.0Mfiling
Jun 22, 2026Collins Helen LouiseCHIEF MEDICAL OFFICERS SaleOE—$43.80$219Kfiling
Jun 22, 2026Hohl BenjaminCFOS SaleOE—$43.80$264Kfiling
Jun 17, 2026Orbimed Advisors LLC10%S Sale—$45.02$12.7Mfiling
Jun 9, 2026Kunkel Lori AnneDirS Sale—$34.54$345Kfiling